Test Price
2,800 AED✅ Home Collection Available
GABRB1 Gene Early Infantile Epileptic Encephalopathy Type 45 Genetic Test in UAE | 2800 AED | DNA Labs UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The GABRB1 NGS test detects pathogenic variants in the GABRB1 gene associated with early infantile epileptic encephalopathy type 45 (EIEE45), a severe neonatal neurodevelopmental disorder. Our Next-Generation Sequencing (NGS) platform ensures comprehensive coverage and variant classification, enabling definitive diagnosis and informed therapeutic decisions.
| Feature | Our Test – GABRB1 NGS | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | 99.9% analytical sensitivity for all coding exons | Lower detection of mosaic variants, ~95% sensitivity for targeted regions |
| Methodology | Next-Generation Sequencing (NGS), validated to ISO 15189 | Capillary electrophoresis-based Sanger sequencing |
| Speed | 3 to 4 weeks | 6 to 8 weeks |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I understand the distress families face when an infant presents with drug-resistant seizures. This genetic test can unlock the precise cause, guiding targeted anti-epileptic therapy and genetic counseling. However, a negative result does not rule out other epileptic encephalopathies, and clinical correlation remains essential.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory: Medication Warning
Do not discontinue prescribed anti-seizure medication without consulting your treating physician.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Inability to provide a blood sample, severe thrombocytopenia requiring special handling.
- ER Red Flags: If the patient experiences status epilepticus, apnea, profound hypotonia, or sudden neurological deterioration, seek immediate emergency care.
- Pre-test: A mandatory genetic counselling session must be completed to draw a three-generation pedigree and document informed consent.
Patient FAQ & Clinical Guidance
1. What is the purpose of the GABRB1 genetic test?
The GABRB1 gene test identifies disease-causing mutations responsible for early infantile epileptic encephalopathy type 45, providing a definitive molecular diagnosis. Once confirmed, clinicians can tailor anti-seizure medications and offer prognostic information. Genetic counselling helps families understand inheritance patterns.
2. How is the sample collected and is it painful?
The test requires a simple blood draw or a one-drop blood spot on an FTA card; our VIP phlebotomist uses paediatric-friendly techniques to minimise discomfort. For infants, a heel-prick or venous sample is obtained in a home setting under cold-chain transport.
3. How long does it take to receive results?
Results are typically available within 3 to 4 weeks; a post-telephonic consultation with a clinical geneticist is scheduled to explain the findings. Urgent preliminary reports can be issued for critical cases upon request.
UAE Regulatory & Data Privacy Adherence
Compliance & Legal Notice: This service adheres to UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability. DHA Facility License No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
Clinical & Logistical Metadata
| Test Name | GABRB1 Gene Early Infantile Epileptic Encephalopathy Type 45 NGS Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 weeks |
| Sample Type / Matrix | Peripheral whole blood or FTA blood spot |
| Methodology Used | Next-Generation Sequencing (NGS) – Whole Exome Sequencing for GABRB1 gene |
| ICD-10-CM Code | G40.4 (Other generalized epilepsy and epileptic syndromes) |
| LOINC Code | 21636-6 (Gene mutation analysis) |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians